WELLS PERFORMANCE MATERIALS LIMITED Overview
| Field | Detail |
|---|---|
| Entity profiled | Wells Performance Materials Limited (formerly Wells Plastics Limited) |
| Match rationale | Exact legal-name match to "Wells Plastics Limited" for the period 7 Jun 1984 – 7 Jun 2024; same company number, still active [S10] |
| Current legal name | WELLS PERFORMANCE MATERIALS LIMITED [S10] |
| Former name(s) | WELLS PLASTICS LIMITED (7 Jun 1984 – 7 Jun 2024) [S10] |
| Trading names | Wells PM; Wells Performance Materials; brands BACTIglas™, Reverte™, Compol™ [S59] |
| Company number | 01822612 (England & Wales) [S10] |
| Legal form | Private limited company [S10] |
| Listing status | Not listed. Privately held. The input list's "Public company" classification is incorrect. |
| Founded / incorporated | Incorporated 7 June 1984 [S10]; founded in 1984 by Danny Wells [S59] |
| Jurisdiction | England & Wales (Companies Act) |
| Registered office / HQ | Emerald Way, Stone Business Park, Stone, Staffordshire, ST15 0SR, United Kingdom [S10][S59] |
| SIC code | 22290 – Manufacture of other plastic products [S10] |
| Stock exchange / ticker | None (not listed) |
| ISIN / CUSIP | Not applicable (no listed securities) |
| Fiscal year end | 30 June [S10][S19] |
| Latest filed accounts | Full accounts for the year to 30 June 2025, filed 14 April 2026 (35 pages) [S19] |
| Next accounts due | Year to 30 June 2026, due by 31 March 2027 [S39] |
| Latest confirmation statement | Made 16 September 2026 "with updates" [S19] |
| Immediate parent / PSC | Wellstopco Limited (company no. 14248252), holding ≥75% of shares and voting rights, notified 26 March 2026 [S61] |
| Prior PSC | R&E Holdings Ltd (company no. 03356524), from 22 Sep 2022 to 26 Mar 2026 [S61] |
| Ultimate controlling party | Not publicly disclosed in sources retrieved. Per the 2022 MBO announcements, it is management-owned (Carl Birch, Stuart Law and Dr Gary Ogden) [S52] |
| Employees (latest) | "Nearly 60" (WMG case study, 29 June 2026) [S24]; 60 (PitchBook) [S62]; 57 (Datanyze) [S63] |
| Auditor | Not publicly disclosed in sources retrieved. It is named in the filed full accounts. |
| Market capitalisation | Not applicable (private). Equity value not publicly disclosed. |
| Website | https://wellspm.com (legacy: wellsplastics.com) [S59][S57] |
| Brand websites | bactiglas.com; revertebio.com (launched March 2025); reverteplastics.com (legacy) [S59][S60] |
| Stated capacity | In excess of 12,000 tonnes per annum (current) [S4]. It was over 10,000 t/a at the time of the October 2022 MBO [S52][S53]. |
| Operations | 24/7 manufacturing across four sites in Stone, covering innovation, manufacturing and warehousing [S4] |
| Metric | 2013 | 2022 | 2024 | 2026 |
|---|---|---|---|---|
| Employees (headcount, approx.) | 40 | — | — | 60 |
Sources: "over 40" at the Stone site (British Plastics, c. Jan 2013) [S3]; "nearly 60" (WMG, June 2026) [S24]. One aggregator (a-leads) shows only 25 LinkedIn-linked employees with −7.4% yearly growth [S7]. This reflects LinkedIn coverage rather than true headcount and conflicts with the 57–60 range from other sources.
Wells Performance Materials is a family-founded, now management-owned specialty chemicals manufacturer in Stone, Staffordshire. It describes itself as the largest independent specialist additive masterbatch and compound producer in the United Kingdom. Wells does not make colour masterbatch. Instead, it formulates and compounds functional additives into easy-to-dose carrier pellets for plastics processors and brand owners. These additives include antimicrobials, oxo-biodegradation promoters, slip and antiblock agents, antistatics, UV stabilisers, antioxidants, flame retardants, blowing agents, fragrances, processing aids and purge compounds. Its two proprietary brands, BACTIglas™ (antimicrobial) and Reverte™ (biodegradable additive for polyolefins), give it intellectual property and regulatory know-how unusual for a firm of roughly 60 people. Around these brands sits a toll-compounding and bespoke-formulation business with over 12,000 t/a of capacity. Wells sells into film, packaging, agriculture, automotive, medical and food-contact markets in the UK, Europe and export territories. Its competitive edge rests on handling difficult raw materials, rapid development and regulatory expertise. Its principal exposure is to plastics-policy risk, especially around oxo-degradable additives and PFAS.
What the company does
Wells is an additive masterbatcher and compounder. A masterbatch is a concentrated blend of one or more additives dispersed in a polymer carrier, supplied as pellets. A processor (a film blower, injection moulder or fibre spinner) adds it at a low let-down ratio to base resin to give the finished article a functional property. Many functional additives are powders, liquids, waxes or high-viscosity fluids that are difficult, hazardous or inconsistent to dose directly. Wells' core value proposition is converting these into homogeneous, free-flowing pellets so the customer gets the function without the handling problem [S4][S59].
The company's own description, paraphrased from its website and trade-directory listing, positions it as follows [S4][S59]:
-
the UK's largest independent specialist additive masterbatch and compound manufacturer, with over 12,000 t/a of capacity;
-
working across a wide range of polymer bases, including polyolefins, biopolymers, bio-based and compostable polymers, EVAs, EMAs and nylons;
-
offering pellet formats from conventional strand pellets through die-face-cut to micro-pellets;
-
providing the full chain from product development, pilot trials and material selection to full-scale production, plus a catalogue of off-the-shelf grades;
-
developing, manufacturing and owning the BACTIglas™ and Reverte™ brands.
The Sales & Marketing Director has emphasised that, although Wells performs R&D both internally and for clients, it sees itself as a manufacturer whose goal is commercially viable solutions [S23].
Business model and revenue model
| Revenue stream | Description | Disclosure status |
|---|---|---|
| Proprietary branded additives | BACTIglas™ antimicrobial masterbatches, compounds and powders; Reverte™ biodegradable masterbatches | Revenue split not publicly disclosed |
| Catalogue functional masterbatches | Slip, antiblock, antistatic, UV, antioxidant, flame retardant, blowing agents, fragrance, processing aids, purge compounds | — |
| Bespoke formulations | Customer-specific additive packages developed and manufactured by Wells | — |
| Contract / toll compounding | Manufacturing to customers' own formulations on Wells' twin-screw lines | — |
| Technical services | Development, pilot trials, testing (expanded with a new Instron testing system in 2026) [S24] | Not disclosed; likely embedded in product pricing |
| Biopolymer compounds | Compol™ bio-based and biopolymer materials | — |
Independent characterisation: Revenue is overwhelmingly product revenue (tonnes sold × price per kg), with no material subscription or licensing component in public sources. Branded ranges are sold via direct sales and, since 2012, an expanded international distributor network [S59]. Pricing is likely cost-plus on raw-material indices with a premium for proprietary chemistries, although no pricing disclosures exist.
Value-chain position
| Stage | Players | Wells' role |
|---|---|---|
| Upstream | Polymer producers (resins); additive chemical producers (slip amides, antistatic GMS, HALS UV stabilisers, silver/zinc antimicrobials, transition-metal pro-oxidants, etc.) | Buyer of carrier resins and raw additives |
| Mid-stream | Masterbatch and compound producers | Wells' core position |
| Downstream conversion | Film blowers, sheet extruders, injection moulders, fibre spinners | Primary direct customers |
| End-use | Retailers, brand owners, packaging buyers, medical-device OEMs, agriculture | Often specify Wells' brands (e.g. antimicrobial refuse sacks, biodegradable carrier bags) |
Wells sits in the mid-stream of the plastics value chain:
Customer types and end-markets
| End-market | Representative applications | Key brand / product |
|---|---|---|
| Flexible packaging & film | Slip/antiblock for PE film, antistatic film, stretch and shrink film | Slips, Antiblocks, Antistatics, Processing Aids |
| Retail/carrier bags & refuse sacks | Biodegradable bags, antibacterial refuse sacks | Reverte™, BACTIglas™ |
| Agriculture | UV-stabilised films, biodegradable mulch-type applications | UV masterbatches, Reverte™ |
| Medical devices | Antimicrobial polymer components | BACTIglas™ |
| Food contact / food packaging | Antimicrobial packaging, slip/antiblock | BACTIglas™, Slips |
| Automotive | Flame retardants, stabilisers, bespoke compounds | Flame Retardants, Antioxidants |
| Mass transport | Antimicrobial touch surfaces | BACTIglas™ |
| Point-of-sale / consumer goods | Scented articles, odour masking in recyclate | Fragrances |
| Foams / lightweighting | Endothermic and exothermic chemical foaming | Blowing agents |
| Recycling | Odour elimination and stabilisation of recyclate | Fragrances, Antioxidants |
The company lists end customers in automotive, medical, food, and agriculture [S59], plus food packaging [S24]. Historic investor descriptions add consumer, construction and agriculture [S8][S57]. BACTIglas™ is positioned for medical devices, mass transport and food packaging [S59], with documented use in refuse sacks [S63]. Reverte™ historically had particular success in plastic carrier bags [S51]. Wells also states that it serves customers ranging from polymer producers to medical-device makers [S59].
Strategy
Stated strategic themes (paraphrased from company communications)
-
Repositioning from "plastics" to "performance materials." The June 2024 rebrand was explicitly framed as reflecting a broader portfolio of additive masterbatches and bespoke compounds, a stronger ESG commitment, and clearer communication with customers and stakeholders [S23][S31].
-
Sustainability-enabling additives. Wells frames its role as supporting UK and EU plastics strategies by making standard polymers more recyclable and reusable in demanding applications. Examples include desiccants for recyclate, odour control, antioxidants for re-stabilisation, and PFAS-free processing aids [S1][S60].
-
Technical partnership and commercial conversion. The company stresses commercial manufacture over pure R&D, offering a full pathway from development through pilot to scale [S23][S59].
-
Growth in the UK and Europe and on the global stage. The 2026 testing investment was explicitly tied to growing market share in the UK and Europe and competing globally [S24].
-
Management ownership and incentivisation. The 2022 MBO was positioned as aligning the executive team with long-term success [S52].
Initiative register (last 24 months, Oct 2024 – Oct 2026)
| Date | Initiative | Category | Detail | Source |
|---|---|---|---|---|
| Jun 2024 (ongoing) | Rebrand to Wells Performance Materials | Corporate / brand | New name, logo and 40th-anniversary event | [S23][S19] |
| Feb 2025 | Commercial team hire (Dean Fosbury) | Organisation | Appointment announced | [S60] |
| Mar 2025 | Reverte™ digital relaunch (revertebio.com) | Brand / marketing | New brand site focused on making ordinary plastics biodegradable | [S60] |
| Apr–Jun 2025 | European trade-show programme | Commercial expansion | Plastteknik Nordic (May 2025); AMI Masterbatch Málaga (June 2025) | [S60] |
| Jun 2025 | Pellet-loss prevention / Operation Clean Sweep leadership | ESG | Profiled by the BPF as setting an industry standard in pellet-loss prevention | [S60] |
| Oct 2025 | EU PFAS regulatory update | Regulatory / product | Customer guidance on EU PFAS restrictions | [S60] |
| Nov 2025 | Microplastics regulatory statement | Regulatory / product defence | Issued by the Regulatory Affairs Manager | [S60] |
| Nov 2025 | Plastics Live Ireland | Commercial | Market development in Ireland | [S60] |
| 2025–26 | Made Smarter West Midlands / WMG digital-investment project | Capex / capability | New Instron testing system, grant of £16k+ | [S24] |
| Mar 2026 | AMI Stretch & Shrink Film, Málaga | Commercial | Film-additive focus | [S60] |
| Apr 2026 | PFAS-free process aids under the PPWR | Product / regulatory | Clarification of compliance of PFAS-free processing aids with the EU Packaging & Packaging Waste Regulation | [S60] |
| Jun 2026 | Interplas 2026 | Commercial | Exhibition reported as successful | [S60] |
| Jun 2026 | Reverte™ microplastic report | Product defence / science | Test results presented as showing no microplastics from Reverte™ technology | [S60] |
| Sep 2026 | AMI Compounding & Recycling Expo (23–24 Sep 2026) | Commercial | Compounding and recycling market positioning | [S60] |
| Sep 2026 | Refinancing (new charge, MBO charges satisfied) | Capital structure | See Sections 6 and 21 | [S19] |
Medium-term financial targets / guidance
None publicly disclosed. As a private company, Wells issues no guidance. The only quantified operational ambition in the public domain is the capacity path (over 10,000 t/a in 2022, over 12,000 t/a currently) [S52][S4].
Products & Services
Launch years are given where disclosed. Pricing is not publicly disclosed for any product line. All descriptions are paraphrased from company materials [S59][S1][S4][S9] unless otherwise cited.
Proprietary brands
| Product / brand | Description & capabilities | Target customers | Launch / version | Notes |
|---|---|---|---|---|
| BACTIglas™ | Antimicrobial masterbatches, compounds and powders that give polymer articles resistance to microbial growth | Medical-device makers, mass-transport interiors, food-packaging converters, refuse-sack producers | Market entry 1999 | Dedicated site bactiglas.com. Datanyze profile notes more than 20 years in antimicrobial grades for health and care applications, including medical devices, food packaging and refuse sacks [S63]. |
| Reverte™ | Additive masterbatches that give conventional polyolefins (PE, PP) a biodegradable property, historically described as oxo-biodegradable | Film and bag producers, retailers; export markets (Middle East, Africa, South America were the 2011 targets) | Technology 2003; brand 2005; new website Mar 2025 | Main driver of the 2011 MBO thesis [S54]. Volumes up about 20% year-on-year around 2012–13 [S3]. A microplastics test report was published June 2026 [S60]. |
| Compol™ | Biopolymer and bio-based materials for extrusion and injection moulding | Converters seeking bio-based or compostable materials | — | Leverages Wells' biopolymer carrier experience [S4] |
Functional additive masterbatches
| Product line | Description | Process / applications | Notes |
|---|---|---|---|
| Slip masterbatches | Lower and control the coefficient of friction in film and moulded parts | Blown/cast film, injection moulding | Catalogue and bespoke grades |
| Antiblock masterbatches | Prevent film layers from sticking (blocking) | Film and sheet | Wide range |
| Antistatic masterbatches | Dissipate static charge | Film, sheet, injection moulding | Wide range |
| UV stabiliser masterbatches | Improve resistance to UV degradation | Agricultural film, outdoor articles; historic founding expertise in 1984 [S59] | Core heritage line |
| Antioxidant masterbatches | Stabilise polymer during processing, in use and during recycling | Broad range of processes | Relevant to recycled-content growth |
| Flame retardant masterbatches & compounds | Bespoke flame-retardant solutions | Automotive, construction, electrical | Bespoke emphasis |
| Blowing agents | Endothermic and exothermic chemical foaming agents as masterbatch or powder | Extrusion and injection moulding; weight reduction | Wells supplies both chemistries [S1] |
| Desiccant masterbatch | High-performance moisture scavenger that cuts filter blocking and film tears caused by large particles | Recycled-feedstock film extrusion | Positioned against lower-cost desiccants [S1] |
| Fragrance masterbatches | Add scent to point-of-sale items or mask unwanted odours in recycled feedstock | Consumer goods, recyclate | Odour-masking supports recycling |
| Processing aids | Improve extrusion quality and appearance while reducing waste and energy use | Film extrusion | PFAS-free grades; regulatory clarification issued Apr 2026 [S60] |
| Purging & cleaning compounds | Help purging, cleaning and shut-down of extrusion equipment | All extruders | Consumable product |
Services
| Service | Description | Capability / evidence |
|---|---|---|
| Bespoke formulation | Custom additive packages from concept to production | Project management, rapid sampling, after-sales follow-up [S59] |
| Contract (toll) compounding | Production to client formulations | Twin-screw lines (two added in 2018) [S2]; 24/7 operation [S4] |
| Pilot trials & material selection | Lab-to-pilot scale-up | Innovation Centre (opened Dec 2022) [S59][S70] |
| Testing & QC | Mechanical and physical property testing | New Instron system, supported by a Made Smarter grant of £16k+ (2026) [S24] |
| Pellet formats | Strand pellet, die-face-cut, micro-pellet | Micro-pellets relevant for rotomoulding and fine dispersion [S4] |
| Regulatory advisory | Guidance to customers, NGOs and national bodies on correct product selection and use | Regulatory Affairs Manager Julie Simmons MRSC; statements on microplastics (Nov 2025) and PFAS (Oct 2025, Apr 2026) [S60] |
Financial Narrative
Data availability statement
Wells files full accounts (31–37 pages) for FY2022 through FY2025 [S19]. Their length and "full" designation suggest the company prepares audited statements with a strategic report, which typically signals a medium-sized company or one that elects full disclosure.
Verified historical datapoints
FY2010 (year to 30 Jun 2010): sales £8.7m, PBT £1.4m [S8]. The ~£10m "reported turnover" is from British Plastics c. Jan 2013 and is approximate; the exact fiscal year is not stated [S3]. A US-centric aggregator estimate of "$6.2M revenue" (Datanyze) attaches a US address in error and is disregarded as unreliable [S63].
Income statement (5-year)
EPS and DPS are not meaningful for a private company with a single corporate shareholder. Revenue CAGR cannot be computed.
Commentary: what can be inferred without the accounts
Although the numbers are unavailable, several qualitative financial signals can be drawn from registry and press evidence.
Scale. The business generated £8.7m of sales in FY2010 [S8] and about £10m around 2013 [S3]. Since then, capacity has risen from roughly the 2013 level through a 25% output increase (2013) and a 40% capacity uplift (2018) to over 12,000 t/a [S3][S2][S4]. Management also states the company has doubled in size over the past decade [S23]. The polymer and additive inflation of 2021–2022 would have added price-driven turnover growth. Taken together, current turnover is plausibly well above the 2013 level. No figure is asserted here; the filed accounts should be consulted.
Profitability heritage. A 16% pre-tax margin in FY2010 [S8] is high for a compounder. It reflects the proprietary-brand mix (Reverte™ was then the growth engine) and supported a private-equity investment thesis. Whether that margin has held up against stricter regulation of oxo-degradable plastics in the EU is a key unknown.
Leverage and financing events. The registry shows a clear capital-structure history:
-
the 2011 MBO used NatWest senior debt [S51];
-
the October 2022 secondary MBO was funded by a Virgin Money package, with four charges (14–17) created on 21 October 2022 [S19][S53];
-
debt was progressively repaid or refinanced, with charge 17 satisfied in October 2024 and legacy charges 12 and 13 in May 2025 [S19];
-
in September 2026 a new charge (18) was registered, and charges 15 and 16 from the MBO were satisfied [S19].
The satisfaction of MBO-era security within four years points to deleveraging and/or a refinancing onto new terms in September 2026. Charge 18 is recorded as satisfied on 14 September 2026, eleven days after it was created [S19]. This is unusual. It could reflect a short bridge facility, a filing correction, or a replaced instrument, and should be checked against the charge documents.
Filing timeliness. The FY2022, FY2023 and FY2025 accounts were filed on 8 April 2023, 10 April 2024 and 14 April 2026 respectively [S19]. Each date falls slightly after the standard nine-month deadline (31 March) for a 30 June year end. Whether filing extensions were granted is not visible in the public record. FY2024 accounts were filed on time (17 March 2025).
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Business Lines
| Business line (analytical) | Contents | Proprietary? |
|---|---|---|
A. Proprietary Brands | BACTIglas™ (antimicrobial); Reverte™ (biodegradable additive for polyolefins) | Yes – own brands and know-how |
B. Functional Additive Masterbatches | Slip, antiblock, antistatic, UV, antioxidant, flame retardant, blowing agents, fragrances, processing aids | Catalogue and bespoke |
C. Specialty Compounds & Biopolymers | Compol™ biopolymer/bio-based compounds; purge and cleaning compounds | Partly proprietary |
D. Contract Services | Toll compounding, bespoke development, pilot trials | Service-based |
Group Entities
| Entity | Company no. | Role | Notes |
|---|---|---|---|
Wellstopco Limited | 14,248,252 | Immediate parent; ≥75% shares and votes since 26 Mar 2026 | Company number sequence suggests incorporation around mid-2022, consistent with use as the Oct 2022 MBO vehicle. This is an inference, not confirmed. [S61] |
R&E Holdings Ltd | 03,356,524 | PSC 22 Sep 2022 – 26 Mar 2026; also held the right to appoint or remove directors | Company number sequence suggests incorporation around 1997, coinciding with the 1997 change of management. Inference only. [S61] |
Wells Performance Materials Limited | 01,822,612 | Trading/operating company | All manufacturing, sales and IP activity appears to sit here |
Income Statement and Margin Analysis (%)
| Metric (GBP Mn) | FY2010 | FY2013 |
|---|---|---|
Revenue | 8.7 | 10 |
Pre-tax profit | 1.4 | — |
Pre-tax margin (%) | 16.1 | — |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansRegion Overview
| Region | Evidence | Assessment |
|---|---|---|
United Kingdom | Described as a very strong UK base; largest independent UK specialist additive masterbatcher [S59] | Core market; probably the largest single country |
Continental Europe | Strong presence in Europe [S59]. Exhibited at AMI Masterbatch (Málaga, June 2025), Plastteknik Nordic (Malmö, May 2025), AMI Stretch & Shrink Film (Málaga, 2026). The WMG project aimed to grow share in the UK and Europe [S24][S60]. | Active growth target, especially the Nordics and Iberia |
Ireland | Exhibited at Plastics Live Ireland, November 2025 [S60] | Developing market |
Middle East, Africa, South America | Explicit Reverte™ export targets at the 2011 MBO [S54] | Historically important for Reverte™. Current weight unknown. |
Americas & Far East | Customer base said to stretch from the Americas to the Far East [S59] | Present via distributors |
Southeast Asia | An aggregator records one employee in Southeast Asia [S7] | Possible sales representative. Unconfirmed. |
Capital Markets
| Item | Status |
|---|---|
Share price performance (1/3/5-year) | Not applicable (not listed) |
Analyst consensus | None (no coverage) |
Dividend history and policy | Not publicly disclosed (dividends to the parent would appear in the accounts) |
Credit ratings (Moody's / S&P / Fitch) | Not rated |
Debt providers | NatWest (to 2022) [S3][S51]; Virgin Money UK (from Oct 2022) [S53]; lender of the Sep 2026 charge not identified |
Balance Sheet
| Funding event (GBP Mn) | FY2011 | FY2013 |
|---|---|---|
Private equity / shareholder equity injected | 3.8 | 1.5 |
Peer Comparison
| Peer | Market cap | Revenue (ttm) | Implied EV/Sales |
|---|---|---|---|
Symphony Environmental (AIM: SYM) | About £19.5m (7 Jul 2026) | £5.73m (FY2025) | About 3.4x market cap/sales (before net debt or cash adjustment) |
Analyst Conclusions
Management guidance
None published. Qualitative direction from 2025–26 communications [S24][S60]:
-
grow share in the UK and Europe;
-
invest in testing and R&D capability;
-
defend and develop Reverte™ with scientific evidence;
-
lead on PFAS-free and recyclate-enabling additives.
Consensus expectations
None (no analyst coverage).
Bull case
-
Regulation-led product pull. EU PFAS restrictions and recycled-content mandates create demand for exactly the niche additives Wells makes (PFAS-free processing aids, desiccants, odour control, re-stabilisers) [S1][S60]. Large competitors may be slower to serve small-volume, high-specification needs.
-
Capacity and capability already built. Successive expansions (2013, 2018, 2022 Innovation Centre, 2026 Instron) mean growth can come from volume on existing assets [S3][S2][S59][S24]. Satisfying most MBO-era charges by September 2026 suggests improving balance-sheet headroom [S19].
-
Biodegradable-additive cycle turning. The closest peer swung to H1 2026 profit with revenue up 23% [S74], and some non-EU jurisdictions are accepting oxo-type technologies [S71]. A recovering Reverte™ market would give Wells high-margin operating leverage, as in FY2010's 16% PBT margin [S8].
Bear case
-
Reverte™ regulatory risk. EU restrictions and microplastics scrutiny could permanently shrink the addressable market for the technology that underpinned the 2011 investment thesis [S54][S60].
-
Scale and concentration. With about 60 staff and one town of operations [S24][S4], Wells is exposed to single-site disruption, key-person risk and procurement disadvantage against Avient, Ampacet and LyondellBasell.
-
Opacity and governance. A two-person statutory board, apparent recurring late filings and an unusual eleven-day charge in September 2026 [S19][S20] raise questions a lender or acquirer would need to resolve through diligence.
Key catalysts and monitorables (next 12 months)
| Monitorable | Timing | Why it matters |
|---|---|---|
| FY2026 full accounts (YE 30 Jun 2026) | Due by 31 Mar 2027 | First audited view after the rebrand and refinancing; check turnover trend, margin, net debt and filing timeliness |
| Charges register clarification (charges 14 and 18) | Now | Confirms current secured-debt position and lender |
| Shareholding detail in the 16 Sep 2026 confirmation statement | Now | Identifies the beneficial owners behind Wellstopco |
| Directors' ECCTA identity verification | By 30 Oct 2026 | Compliance hygiene |
| EU microplastics, PFAS and Green Claims developments | Rolling | Direct impact on Reverte™ and processing aids |
| EcoVadis medal renewal | Annual | Customer qualification |
| European trade-show conversion (Nordics, Iberia, Ireland) | 2026–27 | Validates the European growth strategy |
| Symphony Environmental interim and FY results | Sep 2026 / mid-2027 | Read-across on biodegradable-additive demand |
Analyst verdict
Wells Performance Materials, still widely known as Wells Plastics, is not the public company the input list suggests. It is a 42-year-old, management-owned specialist manufacturer in Staffordshire. It has carved out a defensible niche as the UK's largest independent producer of functional additive masterbatches and compounds. The core of the investment case is technical depth combined with nimbleness. Wells turns awkward chemistries into easy-to-dose pellets, holds two long-lived proprietary brands in BACTIglas™ and Reverte™, and has invested steadily in capacity and innovation infrastructure. That infrastructure now supports over 12,000 tonnes a year. Its ESG and regulatory credentials are notably mature for a firm of roughly 60 people, and they are now a commercial necessity for supplying multinational converters.
The central strategic tension is product mix. Reverte™, an oxo-type biodegradable additive, drove the high-margin growth that attracted private equity in 2011. It now sits in the crosshairs of EU single-use-plastics and microplastics policy. Management's response is sensible: defend the technology with published test data, while redirecting growth toward regulation-favoured niches such as PFAS-free processing aids, recyclate enablers and biopolymers. Whether that pivot has protected margins cannot be judged from public sources.
On balance, the evidence points to a stable, deleveraging, owner-managed specialist rather than a distressed or high-growth story. MBO-era security has largely been released, capex continues, the team is expanding, and newsflow is steady and benign. The principal diligence flags are governance thinness, apparent late filings and the ambiguous September 2026 charge. Verdict: a credible niche operator with moderate regulatory risk. It is suitable as a supplier or partner, and its acquirability and financial health should be confirmed from the filed accounts before any credit or investment decision.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Role | Appointed | Year of birth (month) | Background |
|---|---|---|---|---|
Carl Birch | Director; Sales & Marketing Director | 1 Jul 2005 | Feb 1971 | Former sales manager (2011). Co-led the 2022 secondary MBO. Public face of the company at trade shows. |
Stuart Bryan Law | Director (since 17 Feb 2011); Company Secretary (since 17 Apr 2009); Finance & Operations Director | 17 Feb 2011 | Apr 1968 | Co-led the 2022 secondary MBO |
Executive Leadership Team
| Name | Title | Notes |
|---|---|---|
Carl Birch | Sales & Marketing Director | Shareholder |
Stuart Law | Finance & Operations Director | Shareholder |
Dr Gary Ogden | Technical Manager / head of Technical Team | Became a shareholder at the 2022 MBO; leads collaborative R&D |
Stephen Bell | Executive Management Team member | Title not disclosed |
Michael Spight | Supply Chain Manager | Led the 2026 Made Smarter / WMG testing investment |
Martin Cooper | Executive Management Team member | Title not disclosed |
Julie Simmons MRSC | Regulatory Affairs Manager | Issued the 2025 microplastics regulatory statement |
Dean Fosbury | Joined February 2025 | Role not confirmed in sources retrieved |
Ted Goold | Chairman (per aggregator only) | May chair at holding-company level or in an advisory capacity. |
Board of Directors — Daniel A. C. (Danny) Wells
| Name | Role | Tenure |
|---|---|---|
Daniel A. C. (Danny) Wells | Founder, director | 1984 – 12 Jun 1997 |
Gladys Y. Wells | Director and Secretary | to 12 Jun 1997 |
Peter Davis | Director | to 12 Jun 1997 |
David A. Nelson | Director / Managing Director | 12 Jun 1997 – 17 Feb 2012 |
Stuart P. D. Teare | Director and Secretary | 12 Jun 1997 – 30 Apr 2006 |
Paul J. Morris | Director | 1 Mar 1999 – 7 Apr 2000 |
Andrew C. Barclay | Technical Director | 1 Jul 2005 – 18 Jun 2012 |
Ryan M. Ashley | Secretary | 1 May 2006 – 17 Apr 2009 |
Paul Richardson | Executive Chairman (2011 MBO; ex-KIK Corp, Cott Corp) | from Feb 2011 |
Andy Gregory | Non-executive director (KCP) | from Feb 2011 |
Dr Neil Partlett | Chief Executive | quoted c. 2013 |
Governance Overview
| Dimension | Assessment |
|---|---|
Independence | No independent directors on the statutory register |
Committees | No audit, remuneration or nomination committees disclosed (not required for a private company) |
Chair/CEO separation | No CEO title currently disclosed. The company is run by an Executive Management Team led by the two director-shareholders. A "Chairman" is cited only by an aggregator [S7]. |
Governance code | No adoption of the Wates Principles disclosed in sources retrieved. |
Identity verification | Both directors' Companies House identity verification is due by 30 October 2026 under ECCTA 2023 [S20] |
Major Shareholders
| Holder | Stake | Basis |
|---|---|---|
Wellstopco Limited | ≥75% shares and voting rights | PSC register, from 26 Mar 2026 |
Underlying owners of Wellstopco | Not disclosed in sources retrieved. The 2022 MBO named Birch, Law and Ogden as shareholders; CB Insights also lists Stuart Law, Carl Birch, Gary Ogden and Key Capital Partners (historic) as investors. | Press / aggregator |
Key Capital Partners | Exited (realised) at the October 2022 secondary MBO | KCP website |
LDC | Listed by PitchBook as an investor | — |
Competitive Landscape
Competitors by Segment
| Business line | Competitor | Type / HQ | Relative positioning vs. Wells |
|---|---|---|---|
Functional additive masterbatch (global) | Avient Corporation (incl. former Clariant Masterbatches) | NYSE-listed, USA | Global scale leader with a broad colour and additive portfolio; far larger |
Functional additive masterbatch (global) | Ampacet Corporation | Private, USA | Large global masterbatch player, strong in film additives |
Functional additive masterbatch | LyondellBasell (former A. Schulman masterbatch) | NYSE-listed, NL/USA | Integrated resin producer with masterbatch arm |
Functional additive masterbatch | Tosaf | Private, Israel | Strong in additive masterbatch for film; European plants |
Functional additive masterbatch | Kafrit Group | Listed in Tel Aviv, Israel | Additive masterbatch specialist (film additives) |
Functional additive masterbatch | Gabriel-Chemie | Private, Austria | European colour and additive masterbatch |
Functional additive masterbatch | Plastika Kritis | Athens-listed, Greece | Large European masterbatch producer, strong in agricultural film |
UK masterbatch peers | Broadway Colours; Silvergate Plastics; Hubron International | Private, UK | Mostly colour- or black-masterbatch focused, so limited overlap with Wells' additive niche |
Biodegradable additives (vs Reverte™) | Symphony Environmental Technologies (d2w) | AIM-listed, UK | Direct oxo-biodegradable competitor; similar scale; the only listed pure-play comparator |
Biodegradable additives (vs Reverte™) | EPI Environmental Products (TDPA) | Private, Canada | Oxo-biodegradable competitor |
Antimicrobial additives (vs BACTIglas™) | Addmaster (Biomaster); BioCote; Microban International; Sanitized AG | Private (UK, UK, USA, Switzerland) | Antimicrobial brand/licensing specialists; several license technology rather than compound |
Peer Comparison FY2013
| Metric | Wells PM (FY to Jun-2025) | Symphony Environmental (FY Dec-2025) |
|---|---|---|
Revenue | — | £5.73m (2024: £6.59m) [S73] |
Revenue growth | — | −13% [S73] |
Gross margin | — | 51% (2024: 46%) [S73] |
Net result | — | Loss of £2.50m [S75] |
Employees | ~60 [S24] | 28 [S75] |
Listing | Private | AIM (SYM); market cap about £19.5m (Jul 2026) [S75] |



